The ICH S9 Guideline Q&A document – published in June 2018 – is designed to clarify some of the most common challenges experienced across the industry when implem...

The planet is currently experiencing global healthcare crises that affect huge populations. From diabetes to Alzheimer’s to mental health conditions, we still lack re...

In this article Professor Matthias Nauck of Universitätsmedizin Greifswald and Roland Leiminger of Bruker BioSpin examine the importance of Biobanks and how they are ...

Emily Burke at Biotech Primer examines Alzheimer’s disease (AD) and how it ranks as one of the toughest nuts to crack within drug discovery and development. Current t...

DNA is the code that has defined humanity for millennia. Until more recently, DNA has determined destiny. There was no escaping its design and code for individuals. I...

Significant progress has been made in the AIDS response since 1988, however ensuring a swift and accurate diagnosis accessible to everyone is still a significant barr...

Among the many responsibilities assigned to medical science liaisons (MSLs) is facilitating company collaboration with thought leaders on clinical trial work. Accordi...

Surface plasmon resonance imaging allows the study of molecules binding in label-free and real-time conditions. The power of the technique comes from its singularitie...

This article by Aziza Manceur from National Research Council Canada describes a project whose goal was to test insulin as a booster for cell growth and virus producti...

The last two years have been some of the most remarkable years in pharmaceutical history. There were 46 FDA approvals in 2017, and this year we have received a record...